Evidence map›Paper›PMID 41431729›Full record

ArticleMaterials today. Bio2025

VRK1 co-delivery mitigates DNA clustering by BAF in TFAMoplex transfection.

Christina Greitens, Philip Maurer, Selen Balkan, Jean-Christophe Leroux, Michael Burger

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christina GreitensInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 3, 8093, Zurich, Switzerland.
Philip MaurerInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 3, 8093, Zurich, Switzerland.
Selen BalkanInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 3, 8093, Zurich, Switzerland.
Jean-Christophe LerouxInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 3, 8093, Zurich, Switzerland.
Michael BurgerInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 3, 8093, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In non-viral gene delivery, DNA entering the cytoplasm is rapidly bound by barrier-to-autointegration factor (BAF) and surrounded by nuclear envelope-like membranes. This process is thought to mitigate the translocation of the DNA from the cytoplasm through the nuclear pores limiting the transfection of interphase cells. To prevent BAF clustering, we developed the protein-based gene delivery system TFAMoplex that uses the human mitochondrial transcription factor A (TFAM) which forms nanoparticles with DNA. In previous studies, we covalently fused the endogenous BAF inactivating enzyme vaccinia-related kinase 1 (VRK1) to TFAM, which, however, did not decrease BAF-mediated clustering of the transfected DNA. Here, we describe a modified TFAMoplex where VRK1 is linked to TFAM via a SpyTag/SpyCatcher linker system (SpyTFAMoplex). With this approach, quantitative image analysis, performed with transfected enhanced green fluorescent protein (EGFP)-BAF overexpressing HeLa cells, showed that cytoplasmic BAF clustering can be counteracted. A SpyTFAMoplex version comprising a kinase-inactive VRK1 mutant (dSpyTFAMoplex) exhibited twice the number of clusters per cell. The decrease in BAF clusters achieved with the active VRK1 system was accompanied by lower transfection efficiency in HeLa cells with significantly less (-72 %) mean fluorescence intensity of reporter gene expression compared to dSpyTFAMoplex. These data suggest that VRK1 in the SpyTFAMoplex interferes with BAF's DNA-binding ability, potentially impairing the mitotic nuclear entry pathway of exogenous DNA. While our study highlights the potential of co-delivering enzymes with DNA, further vector engineering is required to directly guide cytosolic DNA into the nucleus of interphase cells.

Indexed as

BAF phosphorylationIntracellular imagingNanoparticlesNon-viral gene deliveryProtein-based transfectionVRK1

Identifiers

PMID41431729
PMCPMC12718190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.